Risk-based prostate cancer screening: who and how?

Area of Science:

• Urology
• Oncology
• Medical Diagnostics

Background:

• Prostate cancer screening aims to reduce mortality but faces challenges with overdiagnosis and overtreatment.
• Established risk factors include increasing age, race, and family history.

Purpose of the Study:

• To identify clinical risk factors for prostate cancer.
• To evaluate current prostate cancer screening tools and their limitations.
• To explore novel diagnostic and characterization methods.

Main Methods:

• Review of clinical risk factors for prostate cancer.
• Assessment of the utility and limitations of current screening tools.
• Exploration of emerging technologies like multiparametric imaging, biomarkers, and genetic profiling.

Main Results:

• Prostate-specific antigen (PSA) is a key factor but requires contextual assessment with other clinical factors.
• Age, race, and family history are significant risk factors for prostate cancer diagnosis.
• Novel tools show promise for enhancing prostate cancer diagnosis and characterization.

Conclusions:

• Optimal use of existing and novel screening tools can mitigate overdiagnosis and overtreatment.
• Future strategies should balance early detection benefits with the risks of unnecessary interventions.
• Continued research into advanced diagnostic tools is crucial for personalized prostate cancer management.